...
首页> 外文期刊>BMC Pregnancy and Childbirth >Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China
【24h】

Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China

机译:孕妇血脂状况与妊娠并发症和围产期结局之间的关联:一项基于人群的中国研究

获取原文

摘要

Background Dyslipidemia in pregnancy are associated with gestational diabetes mellitus (GDM), preeclampsia, preterm birth and other adverse outcomes, which has been extensively studied in western countries. However, similar studies have rarely been conducted in Asian countries. Our study was aimed at investigating the associations between maternal dyslipidemia and adverse pregnancy outcomes among Chinese population. Methods Data were derived from 934 pairs of non-diabetic mothers and neonates between 2010 and 2011. Serum blood samples were assayed for fasting total cholesterol (TC), triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), and low-density lipoprotein-cholesterol (LDL-C) concentrations during the first, second and third trimesters. The present study explored the associations between maternal lipid profile and pregnancy complications and perinatal outcomes. The pregnancy complications included GDM, preeclampsia and intrahepatic cholestasis of pregnancy (ICP); the perinatal outcomes included preterm birth, small/large for gestational age (SGA/LGA) infants and macrosomia. Odds ratios (ORs) and 95?% confidence intervals (95?% CIs) were calculated and adjusted via stepwise logistic regression analysis. Optimal cut-off points were determined by ROC curve analysis. Results After adjustments for confounders, every unit elevation in third-trimester TG concentration was associated with increased risk for GDM (OR?=?1.37, 95?% CI: 1.18-1.58), preeclampsia (OR?=?1.50, 95?% CI: 1.16-1.93), ICP (OR?=?1.28, 95?% CI: 1.09-1.51), LGA (OR?=?1.13, 95?% CI: 1.02-1.26), macrosomia (OR?=?1.19, 95?% CI: 1.02-1.39) and decreased risk for SGA (OR?=?0.63, 95?% CI: 0.40-0.99); every unit increase in HDL-C concentration was associated with decreased risk for GDM and macrosomia, especially during the second trimester (GDM: OR?=?0.10, 95?% CI: 0.03-0.31; macrosomia: OR?=?0.25, 95?% CI: 0.09-0.73). The optimal cut-off points for third-trimester TG predicting GDM, preeclampsia, ICP, LGA and SGA were separately ≥3.871, 3.528, 3.177, 3.534 and ≤2.530?mmol/L. The optimal cut-off points for third-trimester HDL-C identifying GDM, macrosomia and SGA were respectively ≤1.712, 1.817 and ≥2.238?mmol/L. Conclusions Among Chinese population, maternal high TG in late pregnancy was independently associated with increased risk of GDM, preeclampsia, ICP, LGA, macrosomia and decreased risk of SGA. Relative low maternal HDL-C during pregnancy was significantly associated with increased risk of GDM and macrosomia; whereas relative high HDL-C was a protective factor for both of them.
机译:背景技术妊娠中的血脂异常与妊娠糖尿病(GDM),先兆子痫,早产和其他不良后果有关,西方国家对此进行了广泛的研究。但是,在亚洲国家很少进行类似的研究。我们的研究旨在调查中国人群中孕妇血脂异常与不良妊娠结局之间的关系。方法收集2010年至2011年间934对非糖尿病母亲和新生儿的数据。测定血清中的空腹总胆固醇(TC),甘油三酸酯(TG),高密度脂蛋白胆固醇(HDL-C)和孕早期,孕中期和孕晚期的低密度脂蛋白胆固醇(LDL-C)浓度。本研究探讨了孕妇血脂状况与妊娠并发症和围产期结局之间的关系。妊娠并发症包括GDM,先兆子痫和妊娠肝内胆汁淤积(ICP)。围产期结局包括早产,胎龄(SGA / LGA)婴儿的大/小和巨大儿。通过逐步逻辑回归分析计算和调整赔率(OR)和95%置信区间(95%CI)。最佳截止点通过ROC曲线分析确定。结果调整混杂因素后,孕晚期TG浓度每升高一次,就会增加GDM(OR≥1.37,95%CI:1.18-1.58),先兆子痫(OR≥1.50、95%)的风险。 CI:1.16-1.93),ICP(OR≥1.28,95%CI:1.09-1.51),LGA(OR≥1.13,95%CI:1.02-1.26),巨光(OR≥1.19)。 ,95%CI:1.02-1.39)和SGA风险降低(OR?=?0.63,95%CI:0.40-0.99); HDL-C浓度每升高一单位,都会导致GDM和巨人症的风险降低,尤其是在孕中期(GDM:OR?=?0.10,95%CI:0.03-0.31; Macrosomia:OR?=?0.25,95 %CI:0.09-0.73)。 TG预测GDM,先兆子痫,ICP,LGA和SGA的最佳截止点分别≥3.871、3.528、3.177、3.534和≤2.530?mmol / L。妊娠晚期HDL-C鉴别GDM,巨鼻和SGA的最佳临界点分别为≤1.712、1.817和≥2.238?mmol / L。结论在中国人群中,孕晚期孕妇的高TG与GDM,先兆子痫,ICP,LGA,巨子症和SGA风险降低独立相关。孕期相对较低的母亲HDL-C与GDM和巨子症的风险增加显着相关。而相对较高的HDL-C是两者的保护因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号